2017
DOI: 10.17648/ppgcf-2017-66382
|View full text |Cite
|
Sign up to set email alerts
|

Análise de custo-efetividade do tratamento combinado de imunoglobulina humana, plasmaférese e rituximab na rejeição mediada por anticorpo no transplante renal

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles